ES547630A0 - Un metodo para producir una propioxantina - Google Patents

Un metodo para producir una propioxantina

Info

Publication number
ES547630A0
ES547630A0 ES547630A ES547630A ES547630A0 ES 547630 A0 ES547630 A0 ES 547630A0 ES 547630 A ES547630 A ES 547630A ES 547630 A ES547630 A ES 547630A ES 547630 A0 ES547630 A0 ES 547630A0
Authority
ES
Spain
Prior art keywords
kitasatosporia
propioxanthine
produce
propioxatins
goup
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES547630A
Other languages
English (en)
Other versions
ES8701228A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of ES547630A0 publication Critical patent/ES547630A0/es
Publication of ES8701228A1 publication Critical patent/ES8701228A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES547630A 1984-10-04 1985-10-04 Un metodo para producir una propioxantina Expired ES8701228A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59208789A JPS6188884A (ja) 1984-10-04 1984-10-04 エンケフアリナ−ゼｂ阻害物質およびその製法

Publications (2)

Publication Number Publication Date
ES547630A0 true ES547630A0 (es) 1986-11-16
ES8701228A1 ES8701228A1 (es) 1986-11-16

Family

ID=16562134

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547630A Expired ES8701228A1 (es) 1984-10-04 1985-10-04 Un metodo para producir una propioxantina

Country Status (7)

Country Link
US (1) US4804676A (es)
EP (1) EP0177366B1 (es)
JP (1) JPS6188884A (es)
AT (1) ATE84045T1 (es)
CA (1) CA1277623C (es)
DE (1) DE3586935T2 (es)
ES (1) ES8701228A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2746372B2 (ja) * 1988-03-11 1998-05-06 科研製薬株式会社 Ｆ−０３６８物質
US6423688B1 (en) * 1997-07-31 2002-07-23 Athena Neurosciences, Inc. Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4
US6492421B1 (en) 1997-07-31 2002-12-10 Athena Neurosciences, Inc. Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
US6559127B1 (en) * 1997-07-31 2003-05-06 Athena Neurosciences, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6939855B2 (en) * 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
US6362341B1 (en) 1997-07-31 2002-03-26 Athena Neurosciences, Inc. Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
US6583139B1 (en) * 1997-07-31 2003-06-24 Eugene D. Thorsett Compounds which inhibit leukocyte adhesion mediated by VLA-4
US7030114B1 (en) 1997-07-31 2006-04-18 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
JP2003534239A (ja) * 1999-12-17 2003-11-18 ヴァージコア・インコーポレーテッド 新規なスクシナート化合物、組成物、並びに使用及び調製方法
US6797820B2 (en) 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation
US20040006093A1 (en) * 2000-10-17 2004-01-08 Thorsett Eugene D. Compounds which inhibit leukocyte adhesion mediated by VLA-4
AR036053A1 (es) * 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
ES2283589T3 (es) * 2001-06-15 2007-11-01 Vicuron Pharmaceuticals, Inc. Compuestos biciclicos de pirrolidina.
GB0509223D0 (en) 2005-05-05 2005-06-15 Chroma Therapeutics Ltd Enzyme inhibitors
JP2019520550A (ja) 2016-04-21 2019-07-18 スフィンゴテック セラピューティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｄｐｐ３の定量方法および治療方法
CN111542548A (zh) 2017-10-25 2020-08-14 4Teen4制药有限公司 针对并结合于特异性dpp3表位的dpp3结合剂及其在预防或治疗与氧化应激相关的疾病/急性病状中的用途
EP3922993A1 (en) 2020-06-12 2021-12-15 4TEEN4 Pharmaceuticals GmbH Dpp3 in patients infected with coronavirus
CN115769076A (zh) 2020-03-16 2023-03-07 4Teen4制药有限公司 感染冠状病毒的患者中的dpp3
WO2024126793A1 (en) 2022-12-15 2024-06-20 4TEEN4 Pharmaceuticals GmbH Dpp3 inhibitor for improvement of pulmonary function in critically ill patients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284561A (en) * 1979-12-03 1981-08-18 E. R. Squibb & Sons, Inc. Hydroxamic acid derivatives of mercaptoacyl amino acids
JPS5697266A (en) * 1979-12-28 1981-08-05 Tanabe Seiyaku Co Ltd Proline derivative and its preparation
JPS56139455A (en) * 1980-04-02 1981-10-30 Santen Pharmaceut Co Ltd Sulfur-containing acylaminoacid
FR2518088B1 (fr) * 1981-12-16 1987-11-27 Roques Bernard Nouveaux derives d'aminoacides, et leur application therapeutique
JPS6115840A (ja) * 1984-07-03 1986-01-23 Microbial Chem Res Found 免疫賦活剤

Also Published As

Publication number Publication date
CA1277623C (en) 1990-12-11
DE3586935D1 (de) 1993-02-11
DE3586935T2 (de) 1993-07-22
JPH0413358B2 (es) 1992-03-09
EP0177366A3 (en) 1988-08-10
JPS6188884A (ja) 1986-05-07
ES8701228A1 (es) 1986-11-16
EP0177366B1 (en) 1992-12-30
EP0177366A2 (en) 1986-04-09
ATE84045T1 (de) 1993-01-15
US4804676A (en) 1989-02-14

Similar Documents

Publication Publication Date Title
ES547630A0 (es) Un metodo para producir una propioxantina
BG108806A (en) IIb/IIIa CELL ADHESION INHIIBITORS, METHOD FOR THE PRODUCTION, PHARMACEUTCIAL COMPOSITION AND ADMINISTRATION THEREOF
GEP20012580B (en) Substituted 4-Hydroxy-Phenylalcanoic Acid Derivatives With Agonist Activity to PPAR-Gamma, Methods for Their Production, Pharmaceutical Conposition and Methods for Treatment
NO20000841D0 (no) N-Aroylfenylalanin-derivater
EA199800943A1 (ru) Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
MX9307509A (es) Metodo y preparacion farmaceutica para reducir la actividad de las celulas.
IE43916L (en) Allenic prostaglandins
MX9706380A (es) Guanidinas de acidos alquenil-carboxilicos sustituidos con fenilo, procedimientos para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como un medicamento que las contiene.
TR200200263T2 (tr) Yeni seçiçi retinoid agonistleri
GB9903403D0 (en) Substituted stilbene compounds with vascular damaging activity
AU8866882A (en) 2-(n-hydroxycarbamoyl)phenylpropanoyl amino acids
IL126110A0 (en) Use of aryl n-substituted carboxamides to kill tumors and novel compounds for such use
SE9300758D0 (sv) Process for the production of clavulanic acid
JPS56154416A (en) Antipyretic analgesic composition
DK0583271T3 (da) Arylmorpholin, fremstilling og anvendelse
CO4970779A1 (es) Derivados del acido aminoetilfenoxiacetico y agentes para reducir el dolor y promover la eliminacion de calculos en urolitiasis
IL103799A (en) Fish production
FR2392966A1 (fr) Nouveaux acides uree-bis(naphtalene-sulfoniques et naphtalene-carboxyliques), leurs sels pharmaceutiquement acceptables, et leur utilisation therapeutique
TW280810B (es)
ES2147499A1 (es) Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos.
IT1228537B (it) Derivati della cisteina ad azione espettorante
DK315186D0 (da) Morpholinio-carbonsyreester- og morpholinio-alkylphenylethersalte, fremgangsmaade til deres fremstilling og deres anvendelse som fungicider
IT8521435A0 (it) Composizioni insetticide che li derivati di un estere fenilacetico, contengono come ingrediente attivo. procedimento per produrli e
ES456280A1 (es) Un procedimiento para la obtencion de alfa-2,5,9-trimetil- benzo(b)tieno(2,3-f)morfano.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519